STOK

Conviction 40HealthcareScan · Mon, Aug 10, 2026

Bearish harami

STOK$32.25-1.42%

ResistanceSupportVol 14Insider sell

Vol MA14 866.49K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Stoke Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.stoketherapeutics.com ↗

Price32.25

Change-1.42%

Gap-0.31%

Rel volume0.83×

Avg volume770.18K

Avg $ vol23.15M

SMA 2029.94

SMA 5030.44

SMA 20031.57

Price vs 50+5.93%

Price vs 200+2.15%

MA stackmixed

50/200 cross—

Supertrenddown · 33.08

RSI (14)60

MACD hist0.41

MACD crossbull · 5d

Stoch %K / %D84 / 86

ADX (14)20

+DI / −DI21 / 13

RSI divergence—

MACD divergence—

ATR %+4.88%

ADR %5.20%

52w high38.35

52w low13.10

From 52w high-15.92%

Above 52w low+146.15%

New 52w highNo

SqueezeOff

Bollinger width17.95%

%B0.93

Donchian pos85.57%

Donchian high33.09

Donchian low27.24

AVWAP (52w high)32.03

vs AVWAP high+0.68%

AVWAP (52w low)29.50

vs AVWAP low+9.31%

OBV trendUp

Chaikin MF (20)0.25

Today vs 20d0.83×

Avg vol (14d)866.49K

Avg vol (20d)770.18K

Avg $ vol (20d)23.15M

Market cap—

RS 3m (vs SPY)-5.94%

RS 6m (vs SPY)-6.80%

RS line new highNo

Trend template6/8

Technical rank58.4

1 week+9.08%

1 month+2.76%

3 months-1.96%

6 months-0.48%

1 year+143.36%

YTD+4.35%

P/E-306.65

P/B6.11

P/S11.45

P/FCF47.01

EPS-0.1200

Div yield—

ROE-1.99%

ROA-1.75%

Debt/Eq—

Current7.69

EV/EBITDA—

Gross margin—

Net margin-3.73%

Rev growth404.50%

EPS growth92.26%

Price target45.20

Target upside38.14%

Analyst ratingBuy

Institutional120.49%

Ent. value2B

Revenue9.32M

Net income-61.62M

Gross profit—

Free cash flow44.91M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out62.28M

Employees170

ListedWed, Jun 19, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction40 / 100

Pattern quality—

Tech rank58.4 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in STOK

All disclosures →

No recent disclosed trades by Congress in STOK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STOK · 5 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	29.55K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	29.55K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	14.78K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	14.78K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	11.65K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	11.65K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	21K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	21K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	19.44K	—	2026-07-16	2026-07-17
Harrison Seth Loring Director · Stock Option (Right to Buy) · 2026-07-16	Gift	19.44K	—	2026-07-16	2026-07-17

SEC filings

EDGAR filings in STOK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.